Nucleotide substitution: C1049T.
Amino acid replacement: Q286term.
C18687282T
C1049T
Q286term | phtm-PA; Q286term | phtm-PB
Q286term
Early mutant embryos are morphologically normal until approximately stage 14. At stages 15-16, abnormal morphogenetic movements that involve the failure of head involution and defects in dorsal closure become apparent and the embryos become compacted. The embryos have undifferentiated cuticle.
Development of mutant embryos appears normal until about stage 14. At stages 15-16, abnormal morphogenetic movements become apparent, which involve defects in dorsal closure, failure of head involution and aberrant gut looping. When mutant embryos are collected over 12 hours and then allowed to develop for an additional 24 hours, normal germ band retraction is seen in 299 out of 300 embryos.
Mutants fail to make cuticle and show defects in morphogenetic movements during late embryogenesis that lead to a failure of head involution and defective midgut formation.
Poorly differentiated cuticle lacking denticle bands, embryo is contracted posteriorly with a large opening in the head region. Germline clone analysis demonstrate maternal effect abnormal oogenesis.
phmE7 embryos have poorly differentiated cuticle and are contracted posteriorly.
phtmE7 has lethal | recessive phenotype, suppressible by Bmor\Cyp306a1UAS.cNa/Scer\GAL4Act5C.PI
phtmE7 has embryonic/first instar larval cuticle | embryonic stage phenotype, suppressible by talUAS.cKa/Scer\GAL4pnr-MD237
Expression of Bmor\Cyp306a1Scer\UAS.cNa under the control of Scer\GAL4Act5C.PI rescues the lethality of phmE7 in first instar larvae and some of the rescued animals survive to adulthood.
phtmE7 is rescued by phtmUAS.cNa/Scer\GAL4Act5C.PI